<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Pyritinol%2Fen</id>
	<title>Pyritinol/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Pyritinol%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Pyritinol/en&amp;action=history"/>
	<updated>2026-04-07T05:34:38Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Pyritinol/en&amp;diff=134540&amp;oldid=prev</id>
		<title>FuzzyBot: Updating to match new version of source page</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Pyritinol/en&amp;diff=134540&amp;oldid=prev"/>
		<updated>2024-04-04T07:05:34Z</updated>

		<summary type="html">&lt;p&gt;Updating to match new version of source page&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;lt;languages /&amp;gt;&lt;br /&gt;
{{Short description|Chemical compound}}&lt;br /&gt;
{{Infobox drug&lt;br /&gt;
| Verifiedfields = changed&lt;br /&gt;
| verifiedrevid = 464377508&lt;br /&gt;
| IUPAC_name = 5,5&amp;#039;-[dithiobis(methylene)]bis[4-(hydroxymethyl)-2-methylpyridin-3-ol]&lt;br /&gt;
| image = Pyritinol.svg&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename =  &lt;br /&gt;
| pregnancy_category =  &lt;br /&gt;
| legal_status =  &lt;br /&gt;
| routes_of_administration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| bioavailability =  &lt;br /&gt;
| metabolism =  &lt;br /&gt;
| elimination_half-life = 2.5 hours&lt;br /&gt;
| excretion =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| CAS_number_Ref = {{cascite|changed|??}}&lt;br /&gt;
| CAS_number = 1098-97-1&lt;br /&gt;
| ATC_prefix = N06&lt;br /&gt;
| ATC_suffix = BX02&lt;br /&gt;
| PubChem = 14190&lt;br /&gt;
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}&lt;br /&gt;
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}&lt;br /&gt;
| ChemSpiderID = 13561&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = AK5Q5FZH2R&lt;br /&gt;
| KEGG_Ref = {{keggcite|correct|kegg}}&lt;br /&gt;
| KEGG = D02160&lt;br /&gt;
| ChEMBL_Ref = {{ebicite|correct|EBI}}&lt;br /&gt;
| ChEMBL = 488093&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=16 | H=20 | N=2 | O=4 | S=2 &lt;br /&gt;
| smiles = Oc1c(c(cnc1C)CSSCc2c(c(O)c(nc2)C)CO)CO&lt;br /&gt;
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChI = 1S/C16H20N2O4S2/c1-9-15(21)13(5-19)11(3-17-9)7-23-24-8-12-4-18-10(2)16(22)14(12)6-20/h3-4,19-22H,5-8H2,1-2H3&lt;br /&gt;
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChIKey = SIXLXDIJGIWWFU-UHFFFAOYSA-N&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Pyritinol&amp;#039;&amp;#039;&amp;#039; also called pyridoxine disulfide or pyrithioxine (European drug names Encephabol, Encefabol, Cerbon 6) is a semi-synthetic water-soluble analog of [[vitamin B6|vitamin B&amp;lt;sub&amp;gt;6&amp;lt;/sub&amp;gt;]] (Pyridoxine HCl). It was produced in 1961 by Merck Laboratories by bonding 2 vitamin B&amp;lt;sub&amp;gt;6&amp;lt;/sub&amp;gt; compounds ([[pyridoxine]]) together with a disulfide bridge. Since the 1970s, it has been a prescription and OTC drug in several countries for cognitive disorders, rheumatoid arthritis, and learning disorders in children. Since the early 1990s it has been sold as a [[nootropic]] [[dietary supplement]] in the United States.&lt;br /&gt;
&lt;br /&gt;
== Availability ==&lt;br /&gt;
It is approved for &amp;quot;symptomatic treatment of chronically impaired brain function in dementia syndromes&amp;quot; and for &amp;quot;supportive treatment of sequelae of craniocerebral trauma&amp;quot; in various European countries, including Austria, Germany, France, Italy, Portugal, and Greece. In France it is also approved for [[rheumatoid arthritis]] as a [[DMARD|disease modifying drug]], on the basis of the results of clinical trials. In many countries it is available over the counter and is widely advertised on the internet as being for &amp;quot;memory disturbances.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
== Effects ==&lt;br /&gt;
&amp;#039;&amp;#039;review refs needed&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
== Adverse effects ==&lt;br /&gt;
Adverse effects include nausea, headache, and rarely allergic reaction (mild skin reactions).  A 2004 survey of six case reports suggested a link between pyritinol and severe [[cholestatic]] [[hepatitis]] when on several drugs for certain diseases.&lt;br /&gt;
&lt;br /&gt;
Other rare side effects: acute pancreatitis and photoallergic eruption.&lt;br /&gt;
&lt;br /&gt;
== See also ==&lt;br /&gt;
* [[Emoxypine]]&lt;br /&gt;
* [[Pirisudanol]]&lt;br /&gt;
* [[Sulbutiamine]]&lt;br /&gt;
&lt;br /&gt;
==External links==&lt;br /&gt;
*{{Commons category-inline}}&lt;br /&gt;
&lt;br /&gt;
{{Stimulants}}{{Vitamins}}&lt;br /&gt;
&lt;br /&gt;
{{二次利用|date=23 March 2024}}&lt;br /&gt;
[[Category:Antioxidants]]&lt;br /&gt;
[[Category:Nootropics]]&lt;br /&gt;
[[Category:Organic disulfides]]&lt;br /&gt;
[[Category:Pyridines]]&lt;br /&gt;
[[Category:Phenols]]&lt;br /&gt;
[[Category:Primary alcohols]]&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>